Article
Resistance, heteroresistance and fitness costs drive colistin treatment failure during <i>Acinetobacter baumannii</i> pneumonia
2025-07-24
Abstract excerpt
Acinetobacter baumannii is an ESKAPE pathogen linked to healthcare-associated diseases. Due to evolved resistance, last-resort antibiotics such as the lipooligosaccharide (LOS)-targeting colistin are increasingly used to treat multidrug-resistant isolates. To track the evolution of colistin resistance within a host, we performed sequential oropharyngeal infections in immunocompetent or immune-depleted mice in the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fa90e73e-9533-5611-9f86-c7bd596684a7
- DOI
- 10.1101/2025.07.24.666669
